Latest news
-
Chinese cancer immunotherapy drug producer parks over half of the deal with cornerstone investors -
Gaush Meditech is seeking about $80m, and Weilong Global roughly $200m
-
Chinese insurance provider will start taking investor orders at the end of November
-
Chinese nickel producer's deal size takes a hit due to 'gloomy' market outlook
-
Thai Union's pet food unit will start investor roadshow on Wednesday
-
Computer rental firm brings out small deal, but some investors remain sceptical on weak tech sentiment
-
Timing changes but the Koran diagnostics firm's deal size to remain the same
-
Atour revives deal flow but market on the fence on what more to expect
-
Deal flow picks up this week, with more in the works
